[HTML][HTML] Hepatitis B virus infection in the general population of Iran: an updated systematic review and meta-analysis
Results The polled estimated prevalence of HBV infection in the general population of Iran
was 2.2%(95% CI: 1.9%-2.6%). The highest prevalence of HBV infection (8.9%, 95% CI …
was 2.2%(95% CI: 1.9%-2.6%). The highest prevalence of HBV infection (8.9%, 95% CI …
Epidemiology of hepatitis B and the role of vaccination
MS Chang, MH Nguyen - Best Practice & Research Clinical …, 2017 - Elsevier
Hepatitis B virus (HBV) is a major cause of morbidity and mortality with a disproportionate
impact on Asia and Africa. Current guidelines recommend screening at-risk populations for …
impact on Asia and Africa. Current guidelines recommend screening at-risk populations for …
Susceptibility to hepatitis B virus infection in adults living in Spain
V Soriano, A Aguilera, R Benito… - Liver …, 2023 - Wiley Online Library
Background A protective hepatitis B virus (HBV) vaccine has been available for four
decades. Universal HBV vaccination of infants is recommended by the WHO since the …
decades. Universal HBV vaccination of infants is recommended by the WHO since the …
Persistence of protective anti-HBs antibody levels and anamnestic response to HBV booster vaccination: A cross-sectional study among healthcare students 20 years …
G Dini, A Toletone, I Barberis, N Debarbieri… - Human vaccines & …, 2017 - Taylor & Francis
ABSTRACT Vaccination against Hepatitis B Virus (HBV) became mandatory in Italy for all
newborns and 12 years-old individuals in the 1991. The immunogenicity of HBV vaccine …
newborns and 12 years-old individuals in the 1991. The immunogenicity of HBV vaccine …
Vaccine recommendations for solid-organ transplant recipients and donors
Vaccine-preventable infections represent a significant burden of disease in solid-organ
transplant (SOT) recipients. Respiratory infections caused by Streptococcus pneumoniae …
transplant (SOT) recipients. Respiratory infections caused by Streptococcus pneumoniae …
Hepatitis B vaccine and the need for a booster dose after primary vaccination
C Pileggi, R Papadopoli, A Bianco, M Pavia - Vaccine, 2017 - Elsevier
Objectives Protective antibodies levels, induced by Hepatitis B virus (HBV) vaccine, persist
for long-term after primary immunization, but there is evidence that, as the time since …
for long-term after primary immunization, but there is evidence that, as the time since …
[PDF][PDF] A report on the US Vaccine Adverse Events Reporting System (VAERS) of the COVID-19 messenger ribonucleic acid (mRNA) biologicals
J Rose - Science, Public Health Policy, and the Law, 2021 - howbadismybatch.com
Following the global roll-out and administration of the Pfizer/BioNTech (BNT162b2) and
Moderna (mRNA-1 273) COVID-1 9 vaccines1 on December 17, 2020 in the United States …
Moderna (mRNA-1 273) COVID-1 9 vaccines1 on December 17, 2020 in the United States …
Age is an important determinant in humoral and T cell responses to immunization with hepatitis B surface antigen
C Rosenberg, NV Bovin, LV Bram… - Human vaccines & …, 2013 - Taylor & Francis
The aging of the immune system, also named immunosenescence, affects vaccine
responses. However, the onset of age-related immunosenescence has been uncertain, in …
responses. However, the onset of age-related immunosenescence has been uncertain, in …
Melatonin enhances survival and preserves functional integrity of stem cells: A review
Despite state‐of‐the‐art pharmaceutical regimens, continuous improvements in diagnostic
techniques as well as refinements in equipment and interventional procedures, many …
techniques as well as refinements in equipment and interventional procedures, many …
Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination
YL Zhao, BH Han, XJ Zhang, LL Pan, HS Zhou… - BMC infectious …, 2019 - Springer
Background To assess the immune persistence conferred by a Chinese hamster ovary
(CHO)-derived hepatitis B vaccine (HepB) 17 to 20 years after primary immunization during …
(CHO)-derived hepatitis B vaccine (HepB) 17 to 20 years after primary immunization during …